If approved, the panel could be the first of its kind in the United States, and would serve as a companion diagnostic utilized to select patients for specific non-small cell lung cancer therapies.
Read More
The blood-based tests offer results to ordering physicians within 72 hours.
Read MoreThe VeriStrat test is shown to have clinical utility in predicting overall survival of afatinib-treated patients with lung cancer.
Read More
The multichannel spectrometer can measure up to eight different samples at once using a colorimetric enzyme-linked immunosorbent assay.
Read More
The assay is intended for laboratory use to detect the anaplastic lymphoma kinase protein in formalin-fixed, paraffin-embedded, non-small cell lung carcinoma tissue stained using the Ventana BenchMark XT or Ventana BenchMark Ultra automated immunohistochemical slide strainers.
Read More